From the press release archive
Medicine 2021-02-12 1 min read

Green tea compound aids p53, 'guardian of the genome' and tumor suppressor

Research offers new lead for cancer drug discovery
Published 2021-02-12 · Original archive entry · Explore research explainers
Green tea compound aids p53, 'guardian of the genome' and tumor suppressor
Image from the archive · Open full-size image
TROY, N.Y. -- An antioxidant found in green tea may increase levels of p53, a natural anti-cancer protein, known as the "guardian of the genome" for its ability to repair DNA damage or destroy cancerous cells. Published today in Nature Communications, a study of the direct interaction between p53 and the green tea compound, epigallocatechin gallate (EGCG), points to a new target for cancer drug discovery.

"Both p53 and EGCG molecules are extremely interesting. Mutations in p53 are found in over 50% of human cancer, while EGCG is the major anti-oxidant in green tea, a popular beverage worldwide," said END
From the original Press-News collection. Issuers of news releases are responsible for the accuracy of their content.